207 related articles for article (PubMed ID: 6294791)
21. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
22. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
Boussougant Y; Weber P
Presse Med; 1989 Oct; 18(32):1553-5. PubMed ID: 2530530
[TBL] [Abstract][Full Text] [Related]
23. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
24. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
25. [Activity of 14 antimicrobials against Eikenella corrodens].
Vay C; Almuzara M; Barberis C; Rodriguez C; Togneri A; Mattera J; Famiglietti A
Rev Argent Microbiol; 2002; 34(4):230-4. PubMed ID: 12600009
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
27. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.
Liñares J; Alonso T; Pérez JL; Ayats J; Domínguez MA; Pallarés R; Martín R
J Antimicrob Chemother; 1992 Sep; 30(3):279-88. PubMed ID: 1452492
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Tarpay MM; Welch DF; Marks MI
Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
[TBL] [Abstract][Full Text] [Related]
30. [Resistance to penicillin and other antimicrobials in 103 clinical isolations of Streptococcus pneumoniae (2000-2001)].
García-Irure JJ; Navascués A; Martín I; Gastesi C
An Sist Sanit Navar; 2003; 26(1):27-33. PubMed ID: 12759709
[TBL] [Abstract][Full Text] [Related]
31. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
[TBL] [Abstract][Full Text] [Related]
32. [Antibiotic resistance in 622 Streptococcus pneumoniae isolated from blood and cerebrospinal fluid in 33 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000)].
Oteo J; Cruchaga S; Campos J; Sáez-Nieto JA; Baquero F;
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):12-9. PubMed ID: 12550039
[TBL] [Abstract][Full Text] [Related]
33. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of Eikenella corrodens to newer and older quinolones.
Goldstein EJ; Citron DM; Vagvolgyi AE; Gombert ME
Antimicrob Agents Chemother; 1986 Jul; 30(1):172-3. PubMed ID: 3530124
[TBL] [Abstract][Full Text] [Related]
35. [Antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolated in major hospitals in Nagano Prefecture].
Yamazaki Y; Yagi H; Kubo K; Morita M; Hirayama J; Hayasaka M; Harada K; Honda T; Hirai K; Yanagisawa H
Jpn J Antibiot; 2002 Oct; 55(5):524-36. PubMed ID: 12532636
[TBL] [Abstract][Full Text] [Related]
36. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
Schlegel L; Sissia G; Fremaux A; Geslin P
J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
[TBL] [Abstract][Full Text] [Related]
37. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
38. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
39. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
40. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
